Literature DB >> 9580645

Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes.

G Hartmann1, A Krug, M Bidlingmaier, U Hacker, A Eigler, R Albrecht, C J Strasburger, S Endres.   

Abstract

Monocytes are important target cells for anti-inflammatory antisense strategies. However, monocytes are characterized by strong phagocytic and catalytic activity which may limit the effect of antisense oligonucleotides. Intracellular distribution of oligonucleotides in monocytes and the effect of cationic lipids on oligonucleotide uptake in monocytes and other leukocytes have not been evaluated. We investigated cationic lipid-mediated uptake of oligonucleotides in human monocytes and lymphocyte subpopulations. Incorporation of oligonucleotides was quantified by flow cytometry and by confocal microscopy. In the absence of cationic lipids, nearly 100% of monocytes and of B lymphocytes incorporated oligonucleotides compared with only 12% of natural killer cells and 1% of T lymphocytes. The amount of oligonucleotide uptake per cell, as determined by mean fluoresence intensity of positive cells, was four times higher in monocytes than in B lymphocytes. Cationic lipids, which form complexes with oligonucleotides, markedly enhanced the amount of oligonucleotide uptake in all cell types and were most effective at a ratio of 1.1 of positive-to-negative molar charges. In monocytes, oligonucleotides incorporated spontaneously (without a lipid carrier) were trapped in cytoplasmic vesicles. In contrast, cationic lipid-mediated uptake of fluorescence-labeled oligonucleotides resulted in cytoplasmic and nuclear staining. We conclude that 1) monocyte and lymphocyte subpopulations differ in the degree of spontaneous oligonucleotide uptake, and 2) lipofectin both quantitatively and qualitatively affects this uptake. Our results may explain the necessary role of cationic lipids in most antisense models with leukocytes as target cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580645

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

Review 1.  Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.

Authors:  R L Juliano; S Alahari; H Yoo; R Kole; M Cho
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

Review 2.  Signal transduction induced by immunostimulatory CpG DNA.

Authors:  A M Krieg
Journal:  Springer Semin Immunopathol       Date:  2000

3.  Investigation of alpha nascent polypeptide-associated complex functions in a human CD8(+) T cell ex vivo expansion model using antisense oligonucleotides.

Authors:  N Al-Shanti; C G Steward; R J Garland; A W Rowbottom
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

4.  PAMAM dendrimers as delivery agents for antisense oligonucleotides.

Authors:  H Yoo; P Sazani; R L Juliano
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

5.  CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.

Authors:  G Hartmann; G J Weiner; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

6.  Distribution of a 20-mer phosphorothioate oligonucleotide, CGP69846A (ISIS 5132), into airway leukocytes and epithelial cells following intratracheal delivery to brown-norway rats.

Authors:  H Danahay; J Giddings; R A Christian; H E Moser; J A Phillips
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

7.  Heat-shocked monocytes are resistant to Staphylococcus aureus-induced apoptotic DNA fragmentation due to expression of HSP72.

Authors:  K Guzik; M Bzowska; J Dobrucki; J Pryjma
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

8.  Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells.

Authors:  Kristina Domeika; Mattias Magnusson; Maija-Leena Eloranta; Lisbeth Fuxler; Gunnar V Alm; Caroline Fossum
Journal:  Vet Immunol Immunopathol       Date:  2004-09       Impact factor: 2.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.